Skip to main content

Table 3 Percentage of observed agreements between the definitions of the metabolic syndrome among the adults aged 18-69 years residents in Luxembourg, ORISCAV-LUX study

From: Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study

Agreement* Percent ± SE (Cohen's kappa coefficient)

 

JIS-94/80

vs IDF

JIS94/80

vs R-ATPIII

IDF vs R-ATPIII

JIS-94/80

vs IDF

vs R-ATPIII

Total

97.2 ± 0.46 (0.93)

96.7 ± 0.55

(0.91)

93.9 ± 0.65

(0.84)

93.9 ± 0.65

(0.89)

Gender

    

Women

98.9 ± 0.38

(0.96)

98.1 ± 0.54

(0.94)

97.0 ± 0.65

(0.90)

97.0 ± 0.65

(0.94)

Men

95.5 ± 0.84

(0.90)

95.4 ± 0.80

(0.89)

90.8 ± 1.12

(0.78)

90.8 ± 1.12

(0.86)

P-value

0.0003

0.007

< 0.0001

< 0.0001

Age (years)

    

18-29

98.8 ± 0.90

(0.89)

98.5 ± 0.84

(0.83)

97.3 ± 1.22

(0.69)

97.3 ± 1.22

(0.81)

30-39

99.0 ± 0.58

(0.96)

98.6 ± 0.72

(0.94)

97.6 ± 0.92

(0.90)

97.6 ± 0.92

(0.93)

40-49

97.3 ± 0.87

(0.94)

94.6 ± 1.18

(0.87)

91.9 ± 1.43

(0.80)

91.9 ± 1.43

(0.87)

50-59

94.7 ± 1.40

(0.89)

95.4 ± 1.31

(0.91)

90.1 ± 1.85

(0.80)

90.1 ± 1.85

(0.87)

60-69

94.3 ± 1.72

(0.89)

95.7 ± 1.55

(0.92)

89.9 ± 2.22

(0.81)

89.9 ± 2.22

(0.87)

P-value

0.0002

0.001

< 0.0001

< 0.0001

  1. * Percentage of participants who were classified as either having or not having the metabolic syndrome under the considered definitions of the metabolic syndrome.